Systemic Delivery of Human Mesenchymal Stromal Cells Combined with IGF-1 Enhances Muscle Functional Recovery in LAMA2dy/2j Dystrophic Mice

Stem Cell Reviews and Reports

Volumn 9, Issue 1, 2013, Pages 93-109

  Secco, Mariane ^a   Bueno Jr , Carlos ^a   Vieira, Natassia M ^a   Almeida, Camila ^a   Pelatti, Mayra ^a   Zucconi, Eder ^a   Bartolini, Paolo ^b   Vainzof, Mariz ^a   Miyabara, Elen H ^c   Okamoto, Oswaldo K ^a   Zatz, Mayana ^a  

^a Institute of Biosciences   (Brazil)

^b INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

IGF 1; Mesenchymal stromal cells; Muscular dystrophies

Indexed keywords

MUS;

EID: 84873701912     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9380-9     Document Type: Article

References (40)

1. Emery, A. E. (2002). The muscular dystrophies. Lancet, 359, 687-695.
2. O'Brien, K. F., & Kunkel, L. M. (2001). Dystrophin and muscular dystrophy: past, present, and future. Molecular Genetics and Metabolism, 74, 75-88.
3. Dubowitz, V. (1999). 68th ENMC international workshop: on congenital muscular dystrophy, 9-11, April 1999 Naarden, The Netherlands. Neuromuscular Disorders, 9, 446-454.
4. Dalkilic, I., & Kunkel, L. M. (2003). Muscular dystrophies: genes to pathogenesis. Current Opinion in Genetics & Development, 13, 231-238.
5. Kumar, A., Yamauchi, J., Girgenrath, T., & Girgenrath, M. (2011). Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Human Molecular Genetics, 20, 2333-2343.
6. Chamberlain, J. R., & Chamberlain, J. S. (2010). Muscling in: gene therapies for muscular dystrophy target RNA. Nature Medicine, 16, 170-171.
7. Kerkis, I., Ambrosio, C. E., Kerkis, A., et al. (2008). Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: local or systemic? Journal of Translational Medicine, 6, 35.
8. Vieira, N. M., Bueno, C. R., Brandalise, V., et al. (2008). Sjl dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosupression. Stem Cells, 26, 2391-2398.
9. Gang, E. J., Darabi, R., Bosnakovski, D., et al. (2009). Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Experimental Cell Research, 315, 2624-2636.
10. Vieira, N. M., Zucconi, E., Bueno, C. R., et al. (2010). Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice. Stem Cell Reviews and Reports, 6, 560-566.
11. Vieira, N. M., Valadares, M., Zucconi, E., et al. (2011). Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosupression are able to reach the host muscle and express human dystrophin. Cell Transplantation. doi: 10. 3727/096368911X603648.
12. Nitahara-Kasahara, Y., Hayashita-Kinoh, H., Ohshima-Hosoyama, S., et al. (2012). Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with duchenne muscular dystrophy. Molecular Therapy, 20, 168-177.
13. da Justa Pinheiro, C. H., de Queiroz, J. C., Guimarães-Ferreira, L., et al. (2011). Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Reviews and Reports. doi: 10. 1007/s12015-011-9304-0.
14. Zucconi, E., Vieira, N. M., Bueno, C. R., et al. (2011). Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy. Journal of Biomedicine and Biotechnology. doi: 10. 1155/2011/715251.
15. Gang, E. J., Bosnakovski, D., Simsek, T., To, K., & Perlingeiro, R. C. (2008). Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Experimental Cell Research, 314, 1721-1733.
16. Goudenege, S., Pisani, D. F., Wdziekonski, B., et al. (2009). Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Molecular Therapy, 17, 1064-1072.
17. Kocaefe, C., Balci, D., Hayta, B. B., & Can, A. (2010). Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. Stem Cell Reviews and Reports, 6, 512-522.
18. Wagner, J., Kean, T., Young, R., Dennis, J. E., & Caplan, A. I. (2009). Optimizing mesenchymal stem cell-based therapeutics. Current Opinion in Biotechnology, 20, 531-536.
19. Mourkioti, F., & Rosenthal, N. (2005). IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends in Immunology, 26, 535-542.
20. Lynch, G. S., Cuffe, S. A., Plant, D. R., & Gregorevic, P. (2011). IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscular Disorders, 11, 260-268.
21. Gregorevic, P., Plant, D. R., Leeding, K. S., Bach, L. A., & Lynch, G. S. (2002). Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. American Journal of Pathology, 161, 2263-2272.
22. Barton, E. R., Morris, L., Musaro, A., Rosenthal, N., & Sweeney, H. L. (2002). Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. The Journal of Cell Biology, 157, 137-148.
23. Gregorevic, P., Plant, D. R., & Lynch, G. S. (2004). Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle & Nerve, 30, 295-304.
24. Gehrig, S. M., Ryall, J. G., Schertzer, J. D., & Lynch, G. S. (2008). Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Experimental Physiology, 93, 1190-1198.
25. Sacco, A., Doyonnas, R., LaBarge, M. A., et al. (2005). IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. The Journal of Cell Biology, 171, 483-492.
26. Pelosi, L., Giacinti, C., Nardis, C., et al. (2007). Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. The FASEB Journal, 21, 1393-1402.
27. Mills, P., Dominique, J. C., Lafrenière, J. F., Bouchentouf, M., & Tremblay, J. P. (2007). A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. American Journal of Transplantation, 7, 2247-2259.
28. Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 26, 146-150.
29. Vieira, N. M., Brandalise, V., Zucconi, E., et al. (2008). Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. Biology of the Cell, 100, 231-241.
30. Vainzof, M., Ayub-Guerrieri, D., Onofre, P. C., et al. (2008). Animal models for genetic neuromuscular diseases. Journal of Molecular Neuroscience, 34, 241-248.
31. Zatz, M., Zucconi, E., Valadares, M., & Jazedje, T. (2010). Phenotypes in golden retriever. Neuromuscular Disorders, 20, 71.
32. Zucconi, E., Valadares, M. C., Vieira, N. M., et al. (2010). Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog. Neuromuscular Disorders, 20, 64-70.
33. Ichim, T. E., Alexandrescu, D. T., Solano, F., et al. (2010). Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy. Cellular Immunology, 260, 75-82.
34. English, K., French, A., & Wood, K. J. (2010). Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell, 7, 431-442.
35. Caplan, A. I., & Correa, D. (2011). The MSC: an injury drugstore. Cell Stem Cell, 9, 11-15.
36. Gharaibeh, B., Lavasani, M., Cummins, J. H., & Huard, J. (2011). Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Research & Therapy, 2, 31.
37. Ohnishi, S., Sumiyoshi, H., Kitamura, S., & Nagaya, N. (2007). Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Letters, 581, 3961-3966.
38. Lee, M. J., Jung, J., Na, K. H., et al. (2010). Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. Journal of Cellular Biochemistry, 111, 1453-1463.
39. Scicchitano, B. M., Rizzuto, E., & Musarò, A. (2009). Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1. Aging (Albany NY), 1, 451-457.
40. Wingertzahn, M. A., Zdanowicz, M. M., & Slonim, A. E. (1998). Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy. Proceedings of the Society for Experimental Biology and Medicine, 218, 244-250.